Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Systems integration partner

13 May 2005 07:01

Xaar PLC13 May 2005 FOR IMMEDIATE RELEASE 13 May 2005 Xaar plc IMPIKA APPOINTED AS SYSTEMS INTEGRATION PARTNER Xaar plc ("Xaar"), the inkjet printing technology group headquartered inCambridge, and IMPIKA SA ("IMPIKA") of Aubagne, France are pleased to announce ajoint agreement for the provision of integration services for Xaar printheadsand other products. Under the agreement both parties will co-operate to provide complete turnkeysolutions for clients wishing to use Xaar technology for their productionprocesses, to open up new applications and create bespoke solutions. IMPIKA haslong experience with inkjet, including its application to the printing ofplastic and smart cards, packaging, labelling as well as special applicationsfor printing on CDs, glass and metal. Impika is also developing solutions basedon its material jetting technology for microelectronics and biomedicalapplications. Nigel Berry, Deputy CEO of Xaar commented: "I am very pleased to announce thisrelationship with IMPIKA. We previously stated our intention to partner with asmall number of high quality integrators which can offer existing and potentialusers of our technology a complete package of integration skills and bespokeequipment. We have known the team at IMPIKA for some time now and have beenimpressed by their standards and innovation. I look forward to working withthem on future projects." Paul Morgavi, IMPIKA'S CEO said: "Xaar is a great partner for us and we arealready forming strong links with their technical and marketing teams. There isa clear synergy between Xaar and Impika with both parties introducing newmarkets into the joint relationship. Last year we introduced our C9000 productbased on Xaar's Leopard printhead and we are working on various projects foradapting our IPS print engine to the next generation of Xaar printheads, likethe Omnidot and HSS. Full commercial release of these products is anticipatedlater this year or early next year." About Xaar Xaar plc is a market-leading inkjet technology company. It targets the world'sindustrial, commercial and office printing markets. The industrial andcommercial printing markets are targeted by Xaar's own range of inkjet productsin conjunction with partners and other key players in those markets; the officeprinting market is approached through Xaar's strong list of licensees.Additional information about Xaar is available at www.xaar.co.uk. About IMPIKA: Created in March 2003 as a spin-out from Gemplus, IMPIKA is headquartered atAubagne in the south of France. IMPIKA offers high-performance industrialprinting and material jetting solutions using inkjet technology; it currentlyhas 37 employees. IMPIKA designs, develops, implements and markets hardware and softwaresolutions, as well as the required engineering as regards ink and materialjetting, for industrial applications including digital printing,microelectronics and biotechnologies. Additional information about IMPIKA isavailable at www.impika.com. Contacts Xaar plc: 01223-423663Ian Dinwoodie, Chief Executive www.xaar.co.ukNigel Berry, Group Finance Director & Deputy Chief Executive IMPIKA: +33 (0)4 42 62 43 00Paul Morgavi, CEO www.impika.com Bankside Consultants:Steve Liebmann 020-7444-4163 /07802-888159 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th Apr 20063:56 pmRNSDirector/PDMR Shareholding
24th Apr 20064:29 pmRNSResult of AGM
24th Apr 20067:01 amRNSAGM positive trading update
18th Apr 20066:05 pmRNSDirector/PDMR Shareholding
18th Apr 200611:31 amRNSAnnual Information Update
5th Apr 20064:59 pmRNSDirector/PDMR Shareholding
30th Mar 20065:24 pmRNSHolding(s) in Company
14th Mar 20066:21 pmRNSDirector/PDMR Shareholding
14th Mar 20067:01 amRNSFinal Results
21st Feb 20067:01 amRNSNotice of Preliminary Results
14th Feb 20065:29 pmRNSHolding(s) in Company
12th Jan 20067:00 amRNSPeriod-end trading update
29th Nov 20057:00 amRNSHolding(s) in Company
25th Nov 20051:02 pmRNSDirector/PDMR Shareholding
23rd Nov 20055:43 pmRNSDirector/PDMR Shareholding
22nd Nov 20056:30 pmRNSDirector/PDMR Shareholding
7th Nov 20057:00 amRNSAnalyst and investor seminar
3rd Nov 20056:17 pmRNSHolding(s) in Company
24th Oct 20054:13 pmRNSDirector/PDMR Shareholding
24th Oct 20054:11 pmRNSDirector/PDMR Shareholding
24th Oct 20052:47 pmRNSHolding(s) in Company
14th Oct 20056:13 pmRNSHolding(s) in Company
14th Oct 20056:05 pmRNSHolding(s) in Company
12th Oct 200512:44 pmRNSDirector/PDMR Shareholding
10th Oct 20055:22 pmRNSDirector/PDMR Shareholding
6th Oct 20057:00 amRNSHolding(s) in Company
5th Oct 200510:59 amRNSDirector/PDMR Shareholding
27th Sep 20056:11 pmRNSDirector/PDMR Shareholding
20th Sep 20051:06 pmRNSDirector/PDMR Shareholding
14th Sep 20057:02 amRNSAppointment of director
14th Sep 20057:01 amRNSInterim Results
12th Sep 20057:00 amRNSInvestment in trade partner
16th Aug 20055:51 pmRNSNotice of Interim Results
16th Aug 20052:30 pmRNSNotice of Interim Results
28th Jul 20054:32 pmRNSHolding(s) in Company
21st Jul 200510:28 amRNSHolding(s) in Company
6th Jul 20057:00 amRNSPositive half year update
4th Jul 200511:36 amRNSHolding(s) in Company
4th Jul 200511:26 amRNSDirector/PDMR Shareholding
8th Jun 20056:31 pmRNSHolding(s) in Company
2nd Jun 20054:05 pmRNSHolding(s) in Company
26th May 20054:22 pmRNSHolding(s) in Company
26th May 20052:15 pmRNSDirector Shareholding
20th May 20059:28 amRNSHolding(s) in Company
13th May 20057:01 amRNSSystems integration partner
5th May 20056:27 pmRNSHolding(s) in Company
29th Apr 200511:45 amRNSHolding(s) in Company
28th Apr 20052:30 pmRNSResult of AGM
28th Apr 20057:00 amRNSPositive AGM update
25th Apr 20055:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.